These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19521326)

  • 1. The significance of circulating tumor cells as prognostic markers for colon cancer.
    Meropol NJ
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):247-8. PubMed ID: 19521326
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumor cells: will they be clinically useful?
    Nelson NJ
    J Natl Cancer Inst; 2010 Feb; 102(3):146-8. PubMed ID: 20107163
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating endothelial cells as biomarkers of prostate cancer.
    Georgiou HD; Namdarian B; Corcoran NM; Costello AJ; Hovens CM
    Nat Clin Pract Urol; 2008 Aug; 5(8):445-54. PubMed ID: 18682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
    Hanisch E; Hottenrott C; Roukos DH
    Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating microRNAs in cancer: diagnostic and prognostic significance.
    Zhou L; Zhao YP; Liu WJ; Dong J; Chen WY; Zhang TP; Chen G; Shu H
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):283-8. PubMed ID: 22316375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".
    Fehm T; Sauerbrei W
    Breast Cancer Res Treat; 2010 Jul; 122(1):219-20. PubMed ID: 20130980
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
    Faltas B; Zeidan A; Peters K; Das A; Joudeh J; Navaraj A; Dolloff NG; Harvey HA; Jiang Y; Allen JE; Dicker DT; El Deiry WS
    J Clin Oncol; 2011 Jul; 29(21):2946-7; author reply 2947-8. PubMed ID: 21690466
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of blood levels of E-cadherin for diagnosis of colonic cancer].
    Sugawara Y; Ouchi K; Ono H; Kamiyama Y; Fujitani T; Kadokawa Y; Mikuni J; Yamanami H
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):273. PubMed ID: 9750074
    [No Abstract]   [Full Text] [Related]  

  • 11. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance of circulating tumor cells.
    Pantel K; Alix-Panabières C
    Nat Clin Pract Oncol; 2007 Feb; 4(2):62-3. PubMed ID: 17259923
    [No Abstract]   [Full Text] [Related]  

  • 13. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
    Budd GT
    Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic implications of circulating tumor cells in patients with breast cancer.
    Smerage JB; Hayes DF
    Cancer Invest; 2008 Mar; 26(2):109-14. PubMed ID: 18259939
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas.
    Mudan S; Giakoustidis A; Thillainayagam AV; Jacob J; Stebbing J
    Future Oncol; 2010 Jan; 6(1):177-9. PubMed ID: 20021217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in colon cancer: do molecular markers matter?
    Tempero M; Anderson J
    N Engl J Med; 1994 Jul; 331(4):267-8. PubMed ID: 8015575
    [No Abstract]   [Full Text] [Related]  

  • 17. Going with the flow: from circulating tumor cells to DNA.
    Bidard FC; Weigelt B; Reis-Filho JS
    Sci Transl Med; 2013 Oct; 5(207):207ps14. PubMed ID: 24132635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does laparoscopic-assisted colectomy lead to a better oncologic outcome? Still an open question.
    Bozzetti F
    Ann Surg; 2009 May; 249(5):869; author reply 870. PubMed ID: 19387304
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in biomarkers for targeted agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):688-90. PubMed ID: 22402514
    [No Abstract]   [Full Text] [Related]  

  • 20. Putting tumors to the blood test.
    Bender E
    Cancer Discov; 2012 Feb; 2(2):OF6-7. PubMed ID: 22585867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.